QIM
VNDA icon

Quantitative Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Quantitative Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-33,794
Closed -$554K – 836
2019
Q4 		$554K Sell
33,794
-1,303
-4% -$19.7K 0.02% 523
2019
Q3 		$466K Sell
35,097
-2,253
-6% -$31.4K 0.02% 479
2019
Q2 		$526K Buy
37,350
+496
+1% +$7.89K 0.02% 513
2019
Q1 		$678K Buy
+36,854
New +$840K 0.04% 442
2018
Q3 		– Sell
-12,300
Closed -$234K – 891
2018
Q2 		$234K Sell
12,300
-11,600
-49% -$194K ﹤0.01% 684
2018
Q1 		$402K Buy
+23,900
New +$400K 0.01% 668
2017
Q4 		– Sell
-146,200
Closed -$2.62M – 891
2017
Q3 		$2.62M Buy
146,200
+99,700
+214% +$1.67M 0.03% 448
2017
Q2 		$757K Buy
+46,500
New +$670K 0.01% 601
2016
Q3 		– Sell
-24,400
Closed -$273K – 880
2016
Q2 		$273K Buy
24,400
+10,100
+71% +$97.8K 0.01% 641
2016
Q1 		$119K Buy
+14,300
New +$117K 0.01% 726
2015
Q4 		– Sell
-35,400
Closed -$399K – 854
2015
Q3 		$399K Buy
35,400
+13,600
+62% +$166K 0.03% 488
2015
Q2 		$276K Buy
+21,800
New +$235K 0.04% 333
2014
Q2 		– Sell
-44,400
Closed -$721K – 645
2014
Q1 		$721K Buy
+44,400
New +$631K 0.03% 295

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Quantitative Investment Management's VNDA Position: Q1 2020 in Review

Quantitative Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 33,794 shares — an estimated $554K sold.

Quantitative Investment Management first reported a position in VNDA in Q1 2014 and held it in 13 quarters. The position peaked at $2.62M in Q3 2017. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • Quantitative Investment Management reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 33,794 Vanda Pharmaceuticals shares in Q1 2020, an estimated $554K.
  • Quantitative Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 13 quarters.
  • Quantitative Investment Management's Vanda Pharmaceuticals position peaked at $2.62M in Q3 2017.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Quantitative Investment Management's 13F filing for Q1 2020, filed 15 May 2020.